Pace Life Sciences LLC, a full-service contract development and manufacturing organization (CDMO) and subsidiary of Pace Science and Technology Company, has acquired Meridian BioGroup, which specializes in bringing industry experts from regulatory affairs, quality, validation, and related backgrounds to meet its clients’ needs in FDA-regulated environments.
 
“Our clients value our technical expertise and commitment to supporting them in rapidly advancing their programs through the clinic and onto commercialization,” said Eric Roman, CEO of Pace. “The acquisition of Meridian BioGroup adds an array of strategic services to our portfolio to further help clients with regulatory guidance and strategy, and to help them develop and maintain biopharmaceutical operations and quality management systems that meet regulatory requirements.”
 
Expertise gained through the Meridian acquisition allows Pace to extend the following capabilities to its clients:
 

• Regulatory guidance and strategy supporting applications and submissions.
• Quality system development and assessment of existing quality systems.
• Remediation of audit or inspection findings.
• Validation master planning.
• Validation of facility, utility systems, and process equipment.
• Computer system validation.
• Third-party onsite and offsite auditing capabilities.

 
“The addition of the Meridian BioGroup team brings new dimensions to the range of services we provide to our clients,” notes Greg Kupp, President of Pace Life Sciences. “From early regulatory strategy discussions to master planning and validation as programs scale for commercialization, we will be able to help clients at every stage of their journey on through to continued compliance, training, and auditing.”
 
In the coming months, Meridian will transition to the Pace brand. The Meridian operation is in Frederick, Maryland, and joins Pace Life Sciences locations near Boston, MA; Salem, NH; Philadelphia, PA; Ann Arbor, MI; San Diego, CA; St. Paul, MN; and San Germán, PR. Greg Kupp oversees the management and operations of all Pace Life Sciences locations.
 
Pace is a portfolio company of Los Angeles-based Aurora Capital Partners and Leonard Green & Partners.